Integrated First-In-Human And Clinical Pharmacology Programs
Source: Quotient Sciences

When you are looking for a partner who is dedicated to Phase I trials and early development, rely on Quotient Sciences. We accelerate your molecule from first-in-human to proof-of-concept, helping you make critical decisions earlier. Whatever clinical pharmacology study you require, you can expect a fully integrated program from study design to data reporting.
We are dedicated to your Phase I study with our:
- Proven track record of more than 30 years
- 1,300+ Phase I studies completed
- Experts in first-in-human (FIH) and drug-drug interaction (DDI) and thorough QT (TQT) studies
- Industry-leading Phase I medical directors
- Ability to recruit large cohorts ofvolunteers
- Fully integrated programs led by experienced project managers
- In-house data sciences team
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
Quotient Sciences
This website uses cookies to ensure you get the best experience on our website. Learn more